Patent ID: 11891389
Assignee: MYOFORTE THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 12:
13. The compound of claim 1, wherein R1 is selected from C6-10aryl and 5- to 10-membered heteroaryl; wherein said aryl or heteroaryl is optionally substituted with 1 to 3 substituents independently selected from halo, —NR6R7, —OR8, —C(O)R8, —C(O)OR8, —C(O)NR6R7, —SOR9, —SO2R9, —SO2NR6R7, —NR10C(O)R8, C1-6alkyl, C1-6haloalkyl, C3-10cycloalkyl, and 5- to 10-membered heteroaryl.